ALGN vs. WST: Which Stock Is the Better Value Option?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • May 11, 2026

What Makes Align Technology (ALGN) a New Buy Stock

Align Technology (ALGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • May 6, 2026

Align Technology Announces $200 Million Open Market Repurchase

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200.0 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved.

Business Wire • May 1, 2026

ALGN Stock Up Post Q1 Earnings and Revenue Beat, Margins Rise

Align Technology jumps after Q1 earnings beat as record Invisalign shipments, rising margins and steady global demand drive solid revenue growth.

Zacks Investment Research • Apr 30, 2026

Align Technology Showcases Latest Advances in Integrated Digital Orthodontics and Previews 2026 Innovation at AAO Annual Session

ORLANDO, Fla. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared a preview of what orthodontists and their teams can expect from the Company (booth #1643) during the American Association of Orthodontists (AAO) 2026 Annual Session, taking.

Business Wire • Apr 30, 2026

Align Technology beats quarterly estimates, plans $200 million buyback

Align Technology beat Wall Street estimates for first-quarter profit, aided by strong demand for its dental aligners, ​and announced a $200 million share buyback program, sending ‌shares up as much as 4% in after-market trading.

Reuters • Apr 29, 2026

Align Technology, Inc. (ALGN) Q1 2026 Earnings Call Transcript

Align Technology, Inc. (ALGN) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 30, 2026

Align Technology Announces First Quarter 2026 Financial Results, $200M Stock Repurchase, and Reaffirms Fiscal 2026 Guidance

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'26"). Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year. Q1'26 total revenues were favorably impa.

Business Wire • Apr 29, 2026

Align Technology (ALGN) Q1 Earnings and Revenues Surpass Estimates

Align Technology (ALGN) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.13 per share a year ago.

Zacks Investment Research • Apr 29, 2026

Align Technology (ALGN) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Align Technology (ALGN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Apr 29, 2026